TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/04/2025
Voltar para busca
Dado oficial do USPTO
R X +
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
72
Atualização mais recente
16/04/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
25/06/2018
Data de registro
18/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/10/2022
Última transação
16/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
03
Localização do titular
Chuo-ku, Tokyo, JP
Examinador
LINDEMYER, ANKHI
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the letters "R" and "X" and a plus sign.
Titulares e representantes
Titulares
Astellas Pharma Inc.
Representantes
Christopher Bolinger Astellas Pharma Inc.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct
Publicações
Histórico de despachos e eventos da marca no USPTO.
72 publicações encontradas
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/04/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/07/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
18/10/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
15/09/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
31/08/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
31/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/06/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/06/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2022
EX3G
SOU EXTENSION 3 GRANTED
10/02/2022
EXT3
SOU EXTENSION 3 FILED
10/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/02/2022
DOCK
ASSIGNED TO EXAMINER
03/11/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23/09/2021
EX2G
SOU EXTENSION 2 GRANTED
22/09/2021
NREV
NOTICE OF REVIVAL - E-MAILED
20/09/2021
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
20/09/2021
PETG
PETITION TO REVIVE-GRANTED
20/09/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
20/09/2021
EXT2
SOU EXTENSION 2 FILED
08/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/03/2021
EX1G
SOU EXTENSION 1 GRANTED
02/03/2021
EXT1
SOU EXTENSION 1 FILED
02/03/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/03/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/07/2020
PUBO
PUBLISHED FOR OPPOSITION
14/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/06/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/06/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/06/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/05/2020
GNRT
NON-FINAL ACTION E-MAILED
26/05/2020
CNRT
NON-FINAL ACTION WRITTEN
26/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30/04/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
21/01/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
21/01/2020
CNSI
SUSPENSION INQUIRY WRITTEN
21/01/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
13/01/2020
ALIE
ASSIGNED TO LIE
10/01/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
17/06/2019
GNSL
LETTER OF SUSPENSION E-MAILED
17/06/2019
CNSL
SUSPENSION LETTER WRITTEN
17/06/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
13/06/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
12/06/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/06/2019
DRRR
DIVISIONAL REQUEST RECEIVED
22/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/04/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
22/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/10/2018
GNRT
NON-FINAL ACTION E-MAILED
23/10/2018
CNRT
NON-FINAL ACTION WRITTEN
23/10/2018
DOCK
ASSIGNED TO EXAMINER
02/10/2018
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
30/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/06/2018
NWAP
NEW APPLICATION ENTERED
28/06/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace R X + ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.